REGULATED PRESS RELEASE
News
-
-
PRESS RELEASE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages British American Tobacco p.l.c Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BTI
Rosen Law Firm files securities class action lawsuit against British American Tobacco p.l.c. for investors who suffered losses due to alleged understatement of risks. Investors encouraged to join the class action and seek qualified counsel before the March 25, 2024 deadline -
-
PRESS RELEASE
RE Royalties Enters into CAD $1.7 Million Loan and Royalty Agreement with Clean Communities Corp.
RE Royalties Ltd. provides CAD $1.7 Million secured loan to Clean Communities Corporation for a 4MW solar project in Cardston, Alberta. The loan has a 60-month term with 13% interest rate. Royalties and revenues from the project will benefit the company for 20 years -
-
PRESS RELEASE
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.23.
ABIVAX annonce le nombre d'actions et de droits de vote au 31.12.2023 conformément aux réglementations en vigueur. La société est spécialisée en biotechnologie et développe des traitements thérapeutiques pour les maladies inflammatoires chroniques -
-
PRESS RELEASE
ROCTOOL: 2023, renforcement du potentiel de développement
Roctool annonce un chiffre d'affaires annuel 2023 de 9,0 M€, en dépit d'un environnement économique complexe. La société prévoit une accélération de la commercialisation de ses produits en 2024, avec des partenariats stratégiques -
-
REGULATED PRESS RELEASE
MEDESIS PHARMA : Phase 2 clinical trial for the treatment of Alzheimer's disease - Completion of the 1st phase of double-blind treatment, with good patient retention and acceptance of the treatment
MEDESIS PHARMA successfully completes Phase 2 clinical trial for Alzheimer's disease, announces Nanolithium scientific publication, participation in BIOMED Forum, and a new cash contribution
